Ruxolitinib treatment permits lower cumulative glucocorticoid dosing in children with secondary hemophagocytic lymphohistiocytosis

Chi, Y; Liu, R; Zhou, ZX; Shi, XD; Ding, YC; Li, JG

Li, JG (corresponding author), Capital Inst Pediat, Childrens Hosp, Beijing 100020, Peoples R China.

PEDIATRIC RHEUMATOLOGY, 2021; 19 (1):